Completed PHASE4 INTERVENTIONAL 2-arm NCT01831622

Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

Sponsor: Mats Fredriksen

Conditions Attention Deficit-Hyperactivity Disorder

Updated 5 times since 2017 Last updated: Dec 1, 2015 Started: Jun 30, 2013 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01831622, this PHASE4 trial focuses on Attention Deficit-Hyperactivity Disorder and remains completed. Sponsored by Mats Fredriksen, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mats Fredriksen
Norwegian Institute of Public Health
The Hospital of Vestfold
The Research Council of Norway

Data source: University of Oslo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway
• Tønsberg, Norway